CL 4 (Pramipexole dihydrochloride 0.5 mg)
Pill imprint CL 4 has been identified as Pramipexole dihydrochloride 0.5 mg.
Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.